Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells

Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells

Zobrazit další vydání (1)

Factors that regulate the induction of apoptosis of tumour cells are potential candidates for therapeutic intervention for the majority of cancers. Studying modifiers of apoptotic responses, such as members of the tumour necrosis factor receptor superfamily, may give clues as to how induction of apo...

Podrobná bibliografie
Hlavní autoři:	Cross, N, Waterman, E, Jokonya, N, Fowles, A, Buckle, C, Phillips, J, Holen, I, Hamdy, F, Eaton, C
Médium:	Journal article
Jazyk:	English
Vydáno:	2008

Podobné jednotky

Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells.
Autor: Cross, N, a další
Vydáno: (2008)

Imaging the effects of castration on bone turnover and hormone-independent prostate cancer colonization of bone.
Autor: Cross, N, a další
Vydáno: (2008)

Human bone marrow stromal cells protect prostate and breast cancer cells from TRAIL-induced apoptosis
Autor: Nyambo, R, a další
Vydáno: (2004)

The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican.
Autor: Cross, N, a další
Vydáno: (2005)

Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis.
Autor: Nyambo, R, a další
Vydáno: (2004)

Analysis of the functional role of ADAMTS enzymes in prostate cancer
Autor: Molokwu, C, a další
Vydáno: (2005)

The antibody MAB8051 directed against osteoprotegerin detects carbonic anhydrase II: implications for association studies with human cancers.
Autor: Waterman, E, a další
Vydáno: (2007)

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.
Autor: Holen, I, a další
Vydáno: (2002)

Serum osteoprotegerin (OPG) levels and disease progression in prostate cancer patients
Autor: Eaton, C, a další
Vydáno: (2004)

Expression pattern of the ADAMTS (A Disintegrin And Metalloproteinase with ThromboSpondin motifs) proteinases in human prostate cancer celllines
Autor: Chandrasekharan, S, a další
Vydáno: (2003)

Osteoprotegerin is an anti-apoptotic factor produced by prostate cancer cells that is potentially involved in tumour survival and progression.
Autor: Holen, I, a další
Vydáno: (2002)

Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.
Autor: Eaton, C, a další
Vydáno: (2004)

Human bone marrow stromal cell derived IGF signaling enhances PSA production as well as proliferation/survival of androgen sensitive prostate cancer cells in vitro
Autor: Papageorgiou, M, a další
Vydáno: (2005)

EZH2 promotes proliferation and invasiveness of prostate cancer cells.
Autor: Bryant, R, a další
Vydáno: (2007)

Evaluating the role of ADAMTS proteoglycanases and TIMP-3 in prostate cancer progression
Autor: Adeniji, O, a další
Vydáno: (2007)

TIMP-3 expression is regulated by androgen and TNF in prostate stromal and cancer cells
Autor: Adeniji, O, a další
Vydáno: (2008)

TIMP-3 expression in prostate stromal and tumour cells is regulated by androgen and TNF
Autor: Adeniji, O, a další
Vydáno: (2007)

The role of osteoprotegerin in breast and prostate cancer
Autor: Holen, I, a další
Vydáno: (2002)

BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype.
Autor: Darby, S, a další
Vydáno: (2008)

OPG is a survival factor for breast- and prostate cancer cells in vitro
Autor: Holen, I, a další
Vydáno: (2002)

The polycomb group protein EZH2 is required for transcriptional repression of p21 and MMP7 in prostate cancer cells
Autor: Bryant, R, a další
Vydáno: (2007)

Trailing TRAIL Resistance: Novel Targets for TRAIL sensitization in Cancer cells
Autor: RACHANA eTRIVEDI, a další
Vydáno: (2015-04-01)

Overcoming TRAIL-resistance by sensitizing prostate cancer 3D spheroids with taxanes.
Autor: Korie A Grayson, a další
Vydáno: (2021-01-01)

Qualitative and quantitative PSA mRNA detection in prostate cancer - A useful tool for the clinician?
Autor: Phillips, J, a další
Vydáno: (2007)

Dystroglycan function is a novel determinant of tumor growth and behavior in prostate cancer.
Autor: Mitchell, A, a další
Vydáno: (2013)

High susceptibility of metastatic cells derived from human prostate and colon cancer cells to TRAIL and sensitization of TRAIL-insensitive primary cells to TRAIL by 4,5-dimethoxy-2-nitrobenzaldehyde
Autor: Lee Jae-Won, a další
Vydáno: (2011-04-01)

Bone marrow stromal cell-derived insulin-like growth factor (IGF) II enhances growth and survival of prostate cancer cells and potentiates androgen action
Autor: Cross, N, a další
Vydáno: (2007)

Splicing reprogramming of TRAIL/DISC-components sensitizes lung cancer cells to TRAIL-mediated apoptosis
Autor: Oliver H. Voss, a další
Vydáno: (2021-03-01)

HIV induces TRAIL sensitivity in hepatocytes.
Autor: Challagundla K Babu, a další
Vydáno: (2009-01-01)

The emphysematous lung is abnormally sensitive to TRAIL-mediated apoptosis
Autor: Milot Julie, a další
Vydáno: (2011-08-01)

Itraq-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression
Autor: Rehman, I, a další
Vydáno: (2008)

Differential sensitivity of normal osteoblast-like cells and osteosarcoma cells to TRAIL and an agonist antibody to TRAIL receptor-2
Autor: Locklin, R, a další
Vydáno: (2005)

iTRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression.
Autor: Glen, A, a další
Vydáno: (2008)

Apigenin sensitizes prostate cancer cells to Apo2L/TRAIL by targeting adenine nucleotide translocase-2.
Autor: Masakatsu Oishi, a další
Vydáno: (2013-01-01)

Trailing end-point phenotype antibiotic-sensitive strains of Candida albicans produce different amounts of aspartyl peptidases
Autor: L.A. Braga-Silva, a další
Vydáno: (2009-08-01)

iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer.
Autor: Rehman, I, a další
Vydáno: (2012)

Diurnal variation of non-specular meteor trails
Autor: J. Hinrichs, a další
Vydáno: (2009-05-01)

Global variation of meteor trail plasma turbulence
Autor: L. P. Dyrud, a další
Vydáno: (2011-12-01)

Proteomic analysis of voided urine following prostatic massage reveals tumour specific alterations
Autor: Rehman, I, a další
Vydáno: (2004)

Trail without Catheter after Transurethral Resection of Prostate: Clamp It or Not?
Autor: Vikash Talreja, a další
Vydáno: (2016-01-01)